Men with low-risk prostate cancer and hypogonadism may safely receive testosterone therapy Testosterone saturation model suggests limited cancer growth stimulation by normal hormone levels Studies ...

Men who receive testosterone replacement therapy had an increased rate of favorable-risk prostate cancer compared to those who did not use the therapy, and a decreased rate of aggressive prostate ...

In a population of middle-aged and older men with hypogonadism, "the incidences of high-grade or any prostate cancer and other prostate events were low and did not differ significantly between ...

Newswise — Preliminary research suggests that testosterone replacement therapy for men with low testosterone levels appears to have little effect on the prostate gland, contrary to some reports that ...

Testosterone replacement therapy (TRT) is indicated in hypogonadal symptomatic men, where contraindications to treatment do not exist. The International Society for the Study of the Aging Male ...

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2–Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized ...

Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study. This is ...

Adverse effects caused by the decrease in testosterone production in aging men (including depression and changes in muscle and bone tissue) are commonly treated with testosterone replacement therapy ...